Govs. Polis and Brown call on FDA to approve Covid vaccine pooling.
FDA releases its latest batch of Warning Letters that include Evelyn Lopez-Brignoni and Cannafyl.
A review of FDA drug approvals in the last decade covers 378 novel drugs and 27 biosimilars, with 25% of them for oncology indications.
FDA warns a Florida doctor about objectionable conditions in the practices conduct of two clinical trials.
FDA warns Cannafyl it is marketing unapproved and misbranded new drugs for use in humans and an unapproved new animal drug.
FDA tells Acadia Pharmaceuticals that its ongoing review of a supplemental NDA for Nuplazid (pimavanserin), indicated for treating hallucinations and ...
FDA issues a table with recommendations for medical device manufacturers to use in association with an earlier pandemic guidance on notifying the agen...
Sandoz asks the DC federal court to order FDA to set aside its award of new chemical entity status and exclusivity to Sanofi Genzymes Aubagio and to a...